ST and the risk of HCC in men and women
Patients | OR (95% CI) | |||
Model 1* | Model 2† | Model 3‡ | ||
All men | ||||
Long ST | 1934 | 1 (reference) | 1 (reference) | 1(reference) |
Medium ST | 756 | 0.88 (0.79−0.97) | 0.88 (0.79−0.97) | 0.88 (0.79–0.98) |
Short ST | 1054 | 1.04 (0.96−1.13) | 1.03 (0.95−1.12) | 1.01 (0.93–1.10) |
Stratified by HBV/HCV infection without HBV/HCV infection | ||||
Long ST | 868 | 1 (reference) | 1 (reference) | 1 (reference) |
Medium ST | 391 | 0.89 (0.77−1.03) | 0.89 (0.77−1.03) | 0.89 (0.77–1.03) |
Short ST | 535 | 0.92 (0.82−1.04) | 0.92 (0.82−1.04) | 0.92 (0.81–1.04) |
All women | ||||
Long ST | 577 | 1 (reference) | 1 (reference) | 1 (reference) |
Medium ST | 142 | 0.79 (0.63−0.99) | 0.78 (0.62−0.98) | 0.77 (0.62–0.97) |
Short ST | 253 | 0.97 (0.82−1.15) | 0.93 (0.79−1.1) | 0.90 (0.76–1.07) |
Stratified by HBV/HCV infection without HBV/HCV infection | ||||
Long ST | 255 | 1 (reference) | 1 (reference) | 1 (reference) |
Medium ST | 62 | 0.71 (0.51−0.99) | 0.69 (0.49−0.97) | 0.71 (0.50–0.99) |
Short ST | 116 | 0.91 (0.71−1.17) | 0.87 (0.68−1.11) | 0.86 (0.67–1.10) |
Values in bold represent statistically significant results (two-sided p < 0.05)
*Conditional logistic regression matched for sex, age, admission date and admitting hospital.
†Additional adjustment for smoking in Model 1.
‡Additional adjustment for diagnosis of hypertension, type 2 diabetes, dyslipidaemia and obesity in Model 2.
HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; ST, sedentary time.